Amodiaquine plus artesunate versus dihydroartemisinin-piperaquine for drug resistant P.falciparum and P.vivax in Papua, Indonesia

Amodiaquine plus artesunate versus dihydroartemisinin-piperaquine for drug resistant P.falciparum and P.vivax in Papua, Indonesia

Detalles Bibliográficos
Main Authors:	Armedy, R, Hotma, L, Kanagalem, E, Rumaseuw, R, Ebsworth, E, Anstey, N, Tjitra, E, Price, R
Formato:	Journal article
Publicado:	2006

Títulos similares

HEMATOLOGICAL CHANGES IN P.FALCIPARUM & P.VIVAX MALARIA
por: Ameekumari Patel, et al.
Publicado: (2013-03-01)

Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.
por: Hasugian, A, et al.
Publicado: (2007)

A randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine combined with primaquine for radical treatment of vivax malaria in Sumatera, Indonesia.
por: Pasaribu, A, et al.
Publicado: (2013)

Artemisinin-napthoquine versus dihydroartemisinin-piperaquine in adult subjects with Plasmodium vivax infection
por: Armedy Ronny Hasugian, et al.
Publicado: (2016-03-01)

Artemisinin-napthoquine versus dihydroartemisinin-piperaquine in adult subjects with Plasmodium vivax infection
por: Armedy Ronny Hasugian, et al.
Publicado: (2016-03-01)

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy
por: Poespoprodjo, JR, et al.
Publicado: (2014)

Efficacy and safety of dihydroartemisinin-piperaquine in Indonesian children infected with uncomplicated Plasmodium falciparum and Plasmodium vivax
por: Emiliana Tjitra, et al.
Publicado: (2011-12-01)

Efficacy of artesunate–amodiaquine, dihydroartemisinin–piperaquine and artemether–lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger
por: Francesco Grandesso, et al.
Publicado: (2018-01-01)

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy.
por: Jeanne Rini Poespoprodjo, et al.
Publicado: (2014-01-01)

High cure rates and tolerability of artesunate–amodiaquine and dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Kibaha and Kigoma, Tanzania
por: Celine I. Mandara, et al.
Publicado: (2019-03-01)

Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria.
por: Price, R, et al.
Publicado: (2007)

Efficacy of Artemisinin-Naphtoquine and Dihydroartemisinin-Piperaquine for uncomplicated malaria patient at primary health care
por: Hadjar Siswantoro, et al.
Publicado: (2015-01-01)

Efficacy of Artemisinin-Naphtoquine and Dihydroartemisinin-Piperaquine for uncomplicated malaria patient at primary health care
por: Hadjar Siswantoro, et al.
Publicado: (2015-01-01)

Therapeutic response to Dihydroartemisinin-Piperaquine for P. falciparum and P. vivax nine years after its introduction in Southern Papua, Indonesia
por: Poespoprodjo, JR, et al.
Publicado: (2018)

Alternative treatment options for chloroquine resistant Plasmodium vivax in Papua, Indonesia
por: Price, R, et al.
Publicado: (2005)

Treatment policy change to dihydroartemisinin-piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes
por: Poespoprodjo, J, et al.
Publicado: (2015)

The impact of intermittent preventive treatment in school aged children with dihydroartemisinin piperaquine and artesunate amodiaquine on IgG response against six blood stage Plasmodium falciparum antigens.
por: Eric Lyimo, et al.
Publicado: (2025-01-01)

Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine
por: Byakika-Kibwika, P, et al.
Publicado: (2019)

Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis.
por: Karol Marwa, et al.
Publicado: (2022-01-01)

Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
por: Ashenafi Assefa, et al.
Publicado: (2022-12-01)

An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia
por: Valecha, N, et al.
Publicado: (2010)

An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
por: Valecha, N, et al.
Publicado: (2010)

Efficacy and safety of dihydroartemisinin-piperaquine.
por: Myint, H, et al.
Publicado: (2007)

Correction: Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
por: Ashenaf Assefa, et al.
Publicado: (2023-04-01)

Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine
por: Pauline Byakika-Kibwika, et al.
Publicado: (2019-12-01)

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
por: Smithuis, F, et al.
Publicado: (2006)

An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
por: Neena Valecha, et al.
Publicado: (2010-01-01)

Rhino-orbital mucormycosis in a patient with no susceptibility following P.vivax malaria infection—a case report
por: Sonali Prasad, et al.
Publicado: (2022-10-01)

Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.
por: Phyo, A, et al.
Publicado: (2011)

Randomized noninferiority trial of dihydroartemisinin-piperaquine compared with sulfadoxine-pyrimethamine plus amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso
por: Zongo, I, et al.
Publicado: (2015)

Correction: An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia
Publicado: (2010-01-01)

Correction: An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia
Publicado: (2010-01-01)

Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated <it>Plasmodium falciparum</it> malaria in India
por: Gargano Nicola, et al.
Publicado: (2012-07-01)

Correction: An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia.
por: Neena Valecha, et al.
Publicado: (2010-01-01)

Correction: An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia.
por: Neena Valecha, et al.
Publicado: (2010-01-01)

Comparative Studies On Response To 5-Day Treatment With Primaquine Of Indigenous & Imported Cases Of P.Vivax in Nepal in 1974-76
por: A V Kondrashin, et al.
Publicado: (2013-04-01)

A randomized comparison of chloroquine versus dihydroartemisinin-piperaquine for the treatment of Plasmodium vivax infection in Vietnam
por: Thuan, PD, et al.
Publicado: (2016)

A randomized comparison of Chloroquine versus Dihydroartemisinin-Piperaquine for the treatment of Plasmodium vivax infection in Vietnam
por: Thuan, P, et al.
Publicado: (2016)

Therapeutic and Transmission-Blocking  Efficacy of Dihydroartemisinin/Piperaquine and Chloroquine against Plasmodium vivax Malaria, Cambodia
por: Jean Popovici, et al.
Publicado: (2018-08-01)

In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.
por: Hasugian, A, et al.
Publicado: (2009)